Accordingly, inhibiting the NLRP3 inflammasome by TIM-4 via LKB1–AMPKα-mediated autophagy in macrophages suppressed the progression of NAFLD (79). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.